Best Nephrologists in New York City

Dr. James M. Chevalier is a board-certified Nephrologist. He obtained his Medical degree from the Buffalo School of Medicine and Biomedical Sciences, specializing in Nephrology. With expertise in various types of glomerulonephritis, including minimal change disease, FSGS, membranous nephropathy, Ig A nephropathy MPGN, and lupus nephritis, Dr. James is dedicated to providing comprehensive treatment for kidney-related disorders. He has been practicing for 14 years. Dr. James also supports patients with advanced kidney disease, working towards preserving their original kidney function for as long as possible and facilitating a smooth transition to either transplant or home/peritoneal dialysis. He is currently accepting new patients and practices at Rogosin Manhattan East Dialysis, affiliated with New York-Presbyterian. The Rogosin Institute, known for its excellence in diagnosing and treating kidney disease, performed the first kidney transplant in the metropolitan area in 1963.

Dr. Thangamani Muthukumar is an Associate Professor of Medicine at the Weill Cornell Medical College and holds the position of Associate Director for the Nephrology Fellowship Program at Weill Cornell. He obtained his medical degree from the Madras Medical College, Chennai, India and completed his residency in medicine as well as his nephrology fellowship at the Post Graduate Institute of Medical Education and Research, Chandigarh, India. Additionally, he holds a master's degree in clinical and translational investigation from the Weill Cornell Graduate School of Medical Sciences, where he received advanced training in clinical and translational research. He possesses comprehensive expertise in nephrology, hypertension, and transplantation medicine, with a keen interest in advancing the field of kidney transplantation and kidney diseases in bone marrow and stem cell transplantation. Dr. Muthukumar is board certified in internal medicine and nephrology. Dr. Muthukumar underwent nephrology training in both India and the United States. In 2001, he joined the research laboratory of Dr. Manikkam Suthanthiran, a distinguished professor of medicine, as a research fellow in transplantation immunology at Cornell. Dr. Muthukumar actively engages in research focused on the molecular aspects of transplant rejection and biomarkers. He has published numerous papers in this area and receives grants from the National Institutes of Health and the American Society of Transplantation to support his research. Furthermore, Dr. Muthukumar serves as an ad hoc member of the NIH study section and is recognized as a Fellow of the American Society of Transplantation (FAST) and the American Society of Nephrology (FASN). In 2017, he was elected as a member of the American Society for Clinical Investigation (ASCI), a prestigious medical honor society in the United States. He has a high level of proficiency in both English and Hindi languages.

Dr. Phyllis August is a distinguished kidney specialist who completed her education at Harvard College and Yale Medical School. She holds certification in Nephrology from the American Board of Internal Medicine and serves as the Director of the Weill Cornell Hypertension Center. Additionally, she holds the position of Nephrology Fellowship Program Director at the New York-Presbyterian/Cornell Campus. Dr. Phyllis August's research primarily revolves around hypertension and the regulation of blood pressure during pregnancy, as well as hypertension associated with kidney disease. She is deeply committed to providing the highest standard of care and ensuring an exceptional patient experience. She strives to deliver patient-centered services. Her clinical practice at Weill Cornell is largely devoted to hypertension, kidney disease, and obstetric hypertension and kidney disorders. Those seeking her assistance can find her at the Hypertension Center in New York. This esteemed center has made significant advancements in personalized clinical therapies for individual patients. Her office accepts new patients and telehealth appointments.